GLETVAX 6

Regulatory record

Marketing authorisation holder

Zoetis Belgium S.A.

Authorisation number

VPA10387/035/001

Authorisation status

AU

Product type

VM

Pharmaceutical form

Suspension for injection

Route of administration

Intramuscular use; Subcutaneous use

Strength as published

Not stated in source

ATCvet code

QI09AB08

Market

IE

Active ingredients

• Purified toxoids of Cl. perfringens
• Escherichia coli, fimbrial adhesin F4ac
• Escherichia coli, fimbrial adhesin F4ab
• Escherichia coli, fimbrial adhesin F5
• Escherichia coli, fimbrial adhesin F6

Target species

Clinical detail

Dosing, withdrawal periods, contraindications and warnings are not published in this pilot. They live in the product's summary of product characteristics and will only appear here once extracted and checked against the source document.

• aboutextraction pending
• formulations and strengthsextraction pending
• indications and contraindicationsextraction pending
• interactionsextraction pending
• administration and dosageextraction pending
• pharmacologyextraction pending
• suppliersextraction pending
• sourcessource linked